GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness, a company ...

GSK has won its latest trial over whether its former best-selling drug caused cancer on Monday, after a jury found it was not the root cause of an American woman’s illness. Carrie Joiner had alleged ...

UK-based GlaxoSmithKline PLC (GB:GSK) has won the latest U.S. trial concerning its heartburn drug Zantac (ranitidine), amid litigation over alleged cancer risks. The Florida State Court ruled in ...

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer ...

A jury in an Illinois state court found on Monday that British pharmaceutical giant GSK’s (NYSE:GSK) discontinued heartburn medication, Zantac was not responsible for causing colorectal cancer ...

GSK has opted to settle a key lawsuit in its defence against claims that its Zantac drug caused cancer, rather than proceed with a jury trial. The company said this morning it had reached a ...

Pharmaceutical heavyweight GSK on Wednesday said it had settled four lawsuits in the U.S. that claimed its popular heartburn drug Zantac causes cancer, averting a trial due to start in California ...

GSK avoids trial with another Zantac settlement in California. By Kevin Dunleavy Feb 29, 2024 10:15am. Zantac GSK ranitidine lawsuit. For the second time in four weeks, GSK ...

GSK Plc convinced an Illinois jury that the former heartburn drug Zantac was not liable for a woman’s colorectal cancer in a second trial win for the British drugmaker.

(Reuters) - GSK won the latest trial over claims that discontinued heartburn drug Zantac caused cancer, as a jury on Monday found that the drug was not responsible for an Illinois woman's illness ...